# A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together

> **NCT07446400** · PHASE1 · RECRUITING · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Repinatrabit
- **DRUG:** EE/NE
- **DRUG:** Metformin
- **DRUG:** Rosuvastatin
- **DRUG:** Methotrexate
- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT07446400
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2026-06-09
- **Final completion:** 2026-06-15
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07446400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07446400, "A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT07446400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*